During the past decade, Hospital Nacional Profesor Alejandro Posadas conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Profesor Alejandro Posadas" #1 sponsor was "Hospital Nacional Profesor Alejandro Posadas" with 3 trials, followed by "University of Minnesota" with 3 trials sponsored, "Kirby Institute" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Osmotica Pharmaceutical US LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Profesor Alejandro Posadas" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Profesor Alejandro Posadas" are "Dry Eye Syndromes" (2 trials), "HIV Infections" (2 trials), "Corona Virus Infection" (1 trials), "Covid19" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Hospital Nacional Profesor Alejandro Posadas" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Profesor Alejandro Posadas" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "2N(t)RTI" (1 trials), "All licensed antiretroviral medications" (1 trials), "Amniotic membrane extract eye drops (AMEED)" (1 trials), "Dasatinib" (1 trials) and "Glufosfamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Profesor Alejandro Posadas" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Nacional Profesor Alejandro Posadas". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Nacional Profesor Alejandro Posadas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Profesor Alejandro Posadas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".